Peptide-MHC interaction: a rational approach to vaccine design.
Romagnoli
P
P
Central Research Unit, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Takacs
B
B
Kilgus
J
J
Pink
J R
JR
Sinigaglia
F
F
D000595:Amino Acid Sequence; D015195:Drug Design; D006684:HLA-DR Antigens / Q000378:metabolism*; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D011485:Protein Binding; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014614:Vaccines, Synthetic / Q000302:isolation & purification*
D006684:HLA-DR Antigens; D010455:Peptides; D014614:Vaccines, Synthetic